MO
About
MorphoSys AG is a biotechnology companies focusing on fully human antibodies. With its unique technologies, MorphoSys is developing the next generation of antibodies, which can be used to treat diseases and for research and diagnostics purposes. Numerous partnerships have already been entered into with well-known companies from the pharmaceutical and biotechnology sectors, such as Boehringer Ingelheim, Daiichi Sankyo, Merck & Co, Novartis, Pfizer, and Roche.
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 6 investors are based in Planegg, Bayern, Germany.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- healthtech biotech
- Location
- Planegg, Germany
Contact Information
Find more investors like MorphoSys
Search Investors